Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Brief Review on Chemoresistance; Targeting Cancer Stem Cells as an Alternative Approach. | Int J Mol Sci | 2023 | 36901917 | PubTator, text mining | PubMed |
| Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy. | Cancers (Basel) | 2023 | 36900216 | PubTator, text mining | PubMed |
| What Is the Significance of Lysosomal-Mediated Resistance to Imatinib? | Cells | 2023 | 36899844 | PubTator, text mining | PubMed |
| Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or Esomeprazole. | Clin Pharmacokinet | 2023 | 36897544 | PubTator, text mining | PubMed |
| Assessment of the drug-drug interaction potential for therapeutic proteins with pro-inflammatory activities. | Clin Transl Sci | 2023 | 36890677 | PubTator, text mining | PubMed |
| Identification of fatty acid metabolism-related clusters and immune infiltration features in hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 36881382 | PubTator, text mining | PubMed |
| Combined and independent effects of OCT1 and CYP2D6 on the cellular disposition of drugs. | Biomed Pharmacother | 2023 | 36871537 | PubTator, text mining | PubMed |
| Fine particulate matter (PM2.5)-induced pulmonary oxidative stress contributes to changes in the plasma lipidome and liver transcriptome in mice. | Toxicol Sci | 2023 | 36857595 | PubTator, text mining | PubMed |
| Pharmacogenetic impact of SLC22A1 gene variant rs628031 (G/A) in newly diagnosed Indian type 2 diabetes patients undergoing metformin monotherapy. | Pharmacogenet Genomics | 2023 | 36853844 | PubTator, text mining | PubMed |
| miRNAs in Herpesvirus Infection: Powerful Regulators in Small Packages. | Viruses | 2023 | 36851643 | PubTator, text mining | PubMed |
| Interaction of buspirone and its major metabolites with human organic cation transporters. | Fundam Clin Pharmacol | 2023 | 36843181 | PubTator, text mining | PubMed |
| Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. | Pharmaceutics | 2023 | 36839726 | PubTator, text mining | PubMed |
| The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy. | Pharmaceutics | 2023 | 36839686 | PubTator, text mining | PubMed |
| Clocking Epilepsies: A Chronomodulated Strategy-Based Therapy for Rhythmic Seizures. | Int J Mol Sci | 2023 | 36835631 | PubTator, text mining | PubMed |
| Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines. | Int J Mol Sci | 2023 | 36834962 | PubTator, text mining | PubMed |
| An Angiogenic Gene Signature for Prediction of the Prognosis and Therapeutic Responses of Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 36834736 | PubTator, text mining | PubMed |
| Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review. | Biomolecules | 2023 | 36830619 | PubTator, text mining | PubMed |
| Bile duct ligation differently regulates protein expressions of organic cation transporters in intestine, liver and kidney of rats through activation of farnesoid X receptor by cholate and bilirubin. | Acta Pharm Sin B | 2023 | 36815051 | PubTator, text mining | PubMed |
| The importance of nuclear RAGE-Mcm2 axis in diabetes or cancer-associated replication stress. | Nucleic Acids Res | 2023 | 36807739 | PubTator, text mining | PubMed |
| Evaluation of the Impact of Ritlecitinib on Organic Cation Transporters Using Sumatriptan and Biomarkers as Probes. | J Clin Pharmacol | 2023 | 36807251 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=19